Schonfeld Strategic Advisors LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 247 filers reported holding MIRATI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.7%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,337,292
-71.4%
30,700
-76.3%
0.01%
-75.0%
Q2 2023$4,683,747
+452.5%
129,636
+468.6%
0.04%
+400.0%
Q1 2023$847,666
+128.1%
22,799
+178.0%
0.01%
+166.7%
Q4 2022$371,542
-77.3%
8,200
-65.0%
0.00%
-78.6%
Q3 2022$1,636,000
-23.9%
23,427
-26.8%
0.01%
-33.3%
Q2 2022$2,149,000
-10.4%
32,001
+95.7%
0.02%
-4.5%
Q4 2021$2,398,000
-27.6%
16,350
-12.7%
0.02%
-35.3%
Q3 2021$3,313,000
-31.9%
18,727
-37.8%
0.03%
-34.6%
Q2 2021$4,866,000
+1204.6%
30,122
+1680.3%
0.05%
+940.0%
Q4 2020$373,000
+25.6%
1,692
-5.3%
0.01%
-16.7%
Q3 2020$297,000
-76.7%
1,786
-84.0%
0.01%
-64.7%
Q2 2020$1,274,000
-0.5%
11,158
-33.0%
0.02%
-79.0%
Q1 2020$1,280,000
-64.7%
16,655
-40.8%
0.08%
-8.0%
Q4 2019$3,627,000
-62.8%
28,137
-77.5%
0.09%
-69.2%
Q3 2019$9,739,000
-57.1%
125,000
-43.3%
0.29%
-64.4%
Q2 2019$22,702,000
+92.1%
220,400
+36.7%
0.80%
+95.9%
Q1 2019$11,817,000
+206.5%
161,200
+77.3%
0.41%
+177.0%
Q4 2018$3,856,000
+50.2%
90,900
+66.8%
0.15%
+29.8%
Q3 2018$2,567,000
-41.6%
54,500
-38.8%
0.11%
-52.1%
Q2 2018$4,393,000
+649.7%
89,100
+177.5%
0.24%
+395.8%
Q4 2017$586,00032,1130.05%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders